Building an AI Governance Framework for Healthcare Organisations

Author: Eunoia Consulting Co. | Published: May 4, 2026

A comprehensive guide to designing and implementing a robust AI governance framework for healthcare organisations — covering policy, compliance, risk management, and clinical validation.

Key Takeaways

  • Healthcare AI governance requires a dedicated policy layer covering accountability, risk, and clinical validation — not just IT security.
  • FDA SaMD classification determines whether your AI tool is a medical device subject to regulatory clearance.
  • Algorithmic bias audits must be conducted before deployment and at regular intervals post-deployment.
  • A documented AI incident response plan is now a baseline expectation from regulators and payers.
  • Organisations that establish governance frameworks early reduce AI-related liability by an estimated 40–60%.

What Is AI Governance in Healthcare?

AI governance in healthcare refers to the policies, processes, and structures that organisations put in place to ensure their artificial intelligence systems are safe, effective, ethical, and compliant with applicable regulations. As AI becomes embedded in clinical workflows — from diagnostic imaging to predictive risk scoring — the need for robust governance has never been more urgent.

Without a formal governance framework, healthcare organisations face significant risks: regulatory penalties under HIPAA and emerging AI legislation, patient safety incidents from unvalidated models, and reputational damage from opaque or biased AI decisions.

The Five Pillars of Healthcare AI Governance

1. Policy and Accountability

Every AI governance framework begins with clear policies that define who is responsible for AI decisions within the organisation. This includes designating an AI governance committee or officer, establishing escalation pathways for AI-related incidents, and defining the criteria by which AI systems are approved for clinical use.

Accountability structures should mirror existing clinical governance frameworks — AI should not exist in a regulatory vacuum separate from your broader quality and safety systems.

2. Risk Classification and Assessment

Not all AI systems carry the same risk. The FDA's Software as a Medical Device (SaMD) framework classifies AI-powered clinical tools by the severity of harm that could result from incorrect output. Your governance framework should adopt a similar tiered approach:

  • High-risk AI (e.g., diagnostic AI, treatment recommendation systems): Requires rigorous clinical validation, ongoing monitoring, and formal approval processes.
  • Medium-risk AI (e.g., patient scheduling optimisation, revenue cycle automation): Requires documented testing and periodic review.
  • Low-risk AI (e.g., administrative chatbots, appointment reminders): Requires basic documentation and user training.

    • 3. Clinical Validation and Performance Monitoring

    AI models degrade over time as patient populations, clinical practices, and data distributions shift. A governance framework must mandate pre-deployment validation against representative datasets, establish performance benchmarks, and require ongoing monitoring through defined key performance indicators (KPIs).

    Post-market surveillance — borrowed from medical device regulation — is an increasingly expected standard for clinical AI systems.

    4. Data Governance Integration

    AI governance and data governance are inseparable. The quality of AI outputs is entirely dependent on the quality of training and inference data. Your framework must address data provenance, bias assessment, and the handling of protected health information (PHI) under HIPAA.

    Any AI system that processes PHI requires a Business Associate Agreement (BAA) with the vendor and must be included in your HIPAA risk analysis.

    5. Transparency and Explainability

    Healthcare professionals and patients have a right to understand how AI-driven decisions are made. Your governance framework should require that AI vendors provide meaningful explanations of model outputs — particularly for high-stakes clinical decisions. This is not merely an ethical imperative; it is increasingly a regulatory expectation under the EU AI Act and emerging US state legislation.

    Regulatory Landscape

    Healthcare AI governance does not exist in isolation. Key regulatory frameworks include:

  • FDA AI/ML Action Plan: The FDA's evolving framework for AI-based SaMD, including predetermined change control plans.
  • HIPAA: Governs the use of PHI in AI training and inference.
  • EU AI Act: Classifies most clinical AI as "high-risk" with mandatory conformity assessments.
  • ONC Information Blocking Rules: Relevant for AI systems that interact with health information exchange.

    • Getting Started: A Practical Roadmap

  • Inventory your AI systems: Catalogue every AI tool in use across clinical and administrative functions.
  • Classify by risk: Apply a tiered risk framework to prioritise governance efforts.
  • Establish a governance committee: Include clinical, legal, IT, and operational representation.
  • Develop your policy library: Draft policies for AI procurement, validation, monitoring, and incident response.
  • Assess your data governance maturity: AI governance cannot succeed without strong underlying data governance.
  • Engage your vendors: Review BAAs, request model documentation, and understand update and change management processes.

    • > "AI governance is not a one-time project — it is an ongoing organisational capability that must evolve alongside your AI systems and the regulatory environment."

    How Eunoia Consulting Can Help

    Eunoia Consulting Co. specialises in designing and implementing AI governance frameworks for healthcare and veterinary organisations. Our approach is grounded in regulatory expertise, clinical operations experience, and a deep understanding of the practical realities of healthcare AI deployment.

    We offer a structured AI Governance Assessment to benchmark your current maturity across six domains — including FDA SaMD classification, HIPAA compliance, algorithmic bias, and incident response — and a tailored implementation programme to close the gaps. Book a strategy call to discuss your organisation's needs.

    Key Takeaways

  • AI governance is not optional in healthcare — it is a regulatory, ethical, and operational necessity as AI becomes embedded in clinical and administrative workflows.
  • A robust framework requires four pillars: policy and accountability structures, risk classification, vendor oversight, and ongoing performance monitoring.
  • Healthcare organisations should begin with a maturity assessment to establish a baseline before designing governance interventions — not all organisations need the same framework.
  • Board-level engagement is a distinguishing characteristic of organisations with effective AI governance — AI risk must be visible at the highest level of leadership.
  • Governance frameworks should be living documents — reviewed and updated as AI systems evolve, regulations change, and organisational risk profiles shift.